Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Delivery estimate on glucurve canada
Is now may, was feb,
Yes Trade4today. Wouldn't be the first time investors were strung along for years with hollow promises.
Thats great insider info from them
Heard potential “exciting” news coming soon for years. Yet, the needle never moves and the rocket never quite launches.
Maybe this time 🙏
Thanks for sharing. It sounds like things are progressing nicely and the company is finally ready to enjoy the fruits of their hard work over the past few years. I think it’s an exciting time to be an investor. Only time will tell.
Sent the below question to investor relations the other day and his response is below.
Hi, I am a concerned shareholder and would like to know if we can expect news this month. It has been a long time since there has been any press releases and therefore no interest at all in from the investment community which is why the share price is where it is. Is
everything still on track as you indicated a few months ago ?
Yes, we are planning on issuing an update to shareholders in the near future which will give a previous, current, and future summary. While I can’t provide any specific details, I can tell you things are going well and we are extremely excited for 2024. We have seen enormous demand for the GluCurve Pet CGM globally, have interested big name partners on the sidelines waiting for the US relaunch, and have laid the groundwork to launch an ultra-low cost human CGM paired with the ALRT Diabetes Solution in the future.
Thank you for your patience and loyalty as a shareholder, much more information will be provided soon.
V/r
Joe Stern
Head of Animal Health
Joe.Stern@alrt.com
0.0176 / share headed 0.01. Wow! Great stock to own.
With no interest in this company or in this stock, no way to sell without taking a bath. What's our options? Continue to sit and wait while this ticker hovers between 2¢ and 3¢ a share, hoping that someday it gets back up to 4¢ to 6¢ so you can unload at maybe 3¢ to 4¢, or just do what some guy did yesterday and take your lumps at 2¢ when it climbs back up to 3¢? Yikes.
Yes very frustrating… there was alot of shares sold yesterday, just have to continue waiting for results silly to sell before the next round of accomplishments unless of course they dont deliver
Down to 2¢ a share. Lovely. Very encouraging. 😪
ALRTF - same as last year, and the year before, and the year before, and the year before, and the............
Confidence level that this company and its stock value is going up in a significant way this year? I'd say in the neighborhood of 0.05%. But my glass is always half-full! 😄
john glenn, thanks for the update :)
mostly optimistic, just meh. like you said, not much to do but wait. hope your biz is doing great!
best regards,
Booth #453.
Just confirmed on the official Viticus website GLUCURVE PET CGM is booth #453 for the annual WVC conference in Vegas February 18-21st.
Hoping for a good show and a smooth relaunch.
Fair enough Mikey. I feel ya - if you aren't buying and you aren't selling, not much can be done other than waiting.
I still say we are good on this one. Lately - the biggest issue is the previous manufacturer. Seems to me they really slowed progress and potentially affected the relationship with covetrus (again, just speculation on my part).
Good luck to you, Mr. Chan, Joe Stern, the entire staff, all Alrt shareholders and Me (still not rich). Take care....
DOUBLE POST
nice to hear from you, i appreciate your excitement and i really hope mr. chan is able to pull it off...
in truth though, i'm not going to expend any more energy towards getting answers... what will be, will be.
i virtually wrote this stock off regarding any serious gains a while ago... great idea with a promising future, but something is off; either execution or shenanigans.
time will tell, brother :) glty & glta!
hi johnglenn,
nice to hear from you, i appreciate your excitement and i really hope mr. chan is able to pull it off...
in truth though, i'm not going to expend any more energy towards getting answers... what will be, will be.
i virtually wrote this stock off regarding any serious gains a while ago... great idea with a promising future, but something is off; either execution or shenanigans.
time will tell, brother :) glty & glta!
Hey Mikey- when I was looking for information on Covetrus booth, glucurve updates, etc....I also noticed it doesn't appear to be in the current catalog. On 11/9 lastone posted about the show wondering if they would be sharing booth space or seperate.
The timeline mentions product relaunch in February and a clinic study with a "major organization." Both kind of vague, not much detail. I am sure they are unable to share specific details until it has happened.
I don't know this for a fact, but would not surprise me if new relationships have been made for the product relaunch.
I haveappreciated how responsive they have been. Maybe we should send an email to investor relations. Rather than bombard them with a bunch of inquires let's put together ideas for one email and fire it off.
For starters - did Alert participate in VMX this year? Is glucurve still being marketed by covetrus? Is the clinic study being done for a new/additional partnership? They will share Canadian numbers when they have them. What else do inquiring minds want to know?
hi guys,
happy new year :)
i've known for a few months but wanted to see how things played out... maybe it's there, but alrt or glucurve doesn't appear to be listed in the covetrus catalog.
Thought I had read they were attending again this year. You are correct, no mention. Perhaps they skipped this year.
They have us relaunch in February and the WVC show in Vegas mid February.
Their website does not mention them attending The VMX conference.
Thanks for the info Gopher. It kind of bothers me that the company's web site lists the Canada relaunch as completed. I thought that the relaunch for Canada was going to be at the VMX conference. Maybe I missed something - wouldn't be the first time! This is kind of a back burner stock for me and trying to pay more attention to it now. But, with the conference going on now and I thought the relaunch was initially going to happen at this conference, there should have been some kind of PR. Not an insignificant event. Holiday here in the US today with the markets closed, so maybe something (PR) out tomorrow?? But, I doubt it. Oh well, I guess we will find out what is actually going on at the upcoming US WVC conference for US relaunch in late February. Things seem just a bit confusing to me right now.
Thanks for posting and laying it all out. Don't forget, VMX show happening right now. Biggest vet trade show in the states. I thought is was next week, nope right now.
Good list of events. Hopefully they make good progress this year and we have a lot to discuss.
Thanks again....
Looked at the VMX site in regards to booths. Still nothing for ALRT or Glucurve. Must be sharing space with Covetrus. My hope is they have a good show, good timing with the relaunch and updated hardware.
I received the email below from Joe Stern:
Long story short, after we spoke in July we experienced some delays with the interim manufacturer and decided to forego releasing the interim GluCurve CGM hardware model in order to move forward with our long term CGM hardware model that we are currently using and will eventually be adapted for human use. I can’t go into the specifics but there are many advantages for ALRT, shareholders, and our customers ranging from higher margins to more advanced hardware and more that will be released in the near future. We believe the current GluCurve CGM hardware model was well worth the delay because it also solves all the many problems of trying to use a human CGM on pets and the popular human CGM being used off label is our only competition if you can call it that.
We have previously announced numbers regarding diabetic pet populations and over the past few years the growth rate of turning to a human CGM to manage diabetic pets has skyrocketed in our estimates due to the desperate need for a better way of monitoring then in-clinic glucose curves.
I hate to sound like a broken record, but we truly believe we are at the finish line and will be releasing Canadian sales information and US relaunch information along with other updates in the coming weeks and over the next month or two. We are also looking at a number of major partnerships with well-known companies that we have placed on the sidelines until we have fully relaunched that we expect to move forward with in Q2-Q3. If you take a look at the updated investor deck you’ll also see that we expect to be cashflow positive in the coming months.
We sympathize with our loyal shareholders especial with the frustration over the low stock price, but we do not believe putting out PRs stating what we will be doing will bring value and have switched to a strategy of announcing what we have completed as opposed to what we have planned. Please be patient over the next month or two and allow us time to show shareholders and the rest of the market what we have been busy executing on.
Please feel free to share this information with fellow shareholders.
V/r
Joe Stern
Head of Animal Health
Joe.Stern@alrt.com
For those who have not visited the ALRT web site lately, the following is the 2024 calendar of events:
▪ GluCurve Canada product launch Completed
▪ VET Conference, Ontario Canada Completed
▪ GluCurve clinic study with major organization February
▪ GluCurve USA product relaunch February
▪ Western Veterinary Conference (WVC) February 18th-21st
▪ Achieve positive cashflow Q1-Q2, 2024
▪ Pursue major exchange uplisting Q2-Q3, 2024
▪ Pharmaceutical/nutritional partnership Q2-Q3. 2024
▪ GluCurve EU launch Q2-Q3, 2024
▪ Human CGM testing Q2-Q3, 2024
Looks promising. Sure would like to see some positive stats in a PR from the company - been too silent for too long!. Hopefully this will be the year!
Long time investor.
GLTA.
Won't be long and we'll be in the 01's.
Nowhere. That's where we'll be with this ticker. No demand. We're all bag holders with this one.
Damn. Someone coming in with a strong bid at .02. Doubt it fills but would be a good trade. Where we going to be march/April next year?
I am up 27.81% on all my trades this week.
Why would I do that johnglenn? Wish everyone the best. BTW, the share price grew 27.81% today!!!! Woo hoo! We're back to 0.025/share! 😀
You coming for me MckVee?
Lol. I will say this....things need to happen in 2024. They laid out dates, deadlines and goals in the investor packet. In the past, delays could be justified, now goals and objectives need to be met. I appreciate all that has been done to this point and I appreciate the investor packet they put together. Time for results.
Nothing is going to happen the rest of this year. Probably see some more end of year selling. No news. No pr's. If memory serves me correctly they have the Vet conference in FL up next. Big event, lots of exposure, hopefully no manufacturing issues with the re-launch.
Looking forward to next year. I have not lost confidance...in fact picked up some .02's.
Happy holidays to everyone....hopefully we will see some board action early 2024.
Only been like 6 or 7years for me. Same cheerleaders doing the same cheer every year. Yet, this ticker goes nowhere.
I have been running with this stock for decades, seem to be losing the race . Buying opportunities occur every other day as price tanks.
Mckvee might have a point.
It sure isn't showing in share price, is it now? Every year we have lots to look forward to with this company, except growth in share price.
Maybe next year ALRT will climb all the way back to 035 and we can celebrate!
Man. I never have funds cleared and ready to go when a buying opportunity presents itself. Schwab takes forever to clear on otc purchases. Getting some dry powder ready for end of year selling.
$4k traded today, somebody is tax loss selling their position IMO. Nice opportunity for anybody with free funds
They have previously said NYSE which makes sense because it has easier requirements then NASDAQ
Uplisting to which exchange? Nasdaq?
Typical weak hands at end of year. Just wait for pennystock power month of Jan/Feb, it gets very bullish in the entire market.
Did the glucurve study show something disappointing and someone knows it?
We are getting killed
I'd say the company has made good advancements this past year and we do have a lot of positive items on the horizon for 2024.
Another year of just dead money. Same ol' same ol'.
A press release would have been nice, but its good to see the update.
Look encouraging however why no press release instead of just updating website, ?
The timeline is pretty exciting to see, positive cashflow in Q1, uplisting in Q1-Q2, Human CGM testing in Q2-Q3, a major study in December and a pet food partnership in Q1-Q2. Not to mention a US relaunch in January and it looks like they are going to the two largest veterinary conferences in January and February. I wonder if they will have their own booth or if they will do something jointly with Covetrus? I see Covetrus registered for both but I dont see ALRT or GluCurve registered yet on either floorplan...
Followers
|
148
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
13199
|
Created
|
10/05/09
|
Type
|
Free
|
Moderators |
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |